Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072084
Abstract: Simple Summary It is estimated that 30–50 percent of patients treated with Immune Checkpoint Blockers will eventually develop cutaneous immune-related adverse events. These toxicities are in, most of the time, low-grade reactions; however, they are… read more here.
Keywords: adverse reactions; reactions immunotherapy; cutaneous adverse; immunotherapy patients ... See more keywords